Munehiro Kitada, Shin-Ichi Tsuda, Kazunori Konishi, Ai Takeda-Watanabe, Mizue Fujii, Keizo Kanasaki, Makoto Nishizawa, Atsushi Nakagawa, Daisuke Koya. Anagliptin ameliorates albuminuria and urinary liver-type fatty acid-binding protein excretion in patients with type 2 diabetes with nephropathy in a glucose-lowering-independent manner. BMJ Open Diabetes Research and Care. 2017. 5. 1. e000391
2009/07 - 金沢医科大学医学会 A lack of increase in high molecular weight-adiponectin in macroalbuminuric subjects with metabolic syndrome may exert renal and atherosclerotic risks.Diabetes Research and Clinical Practice 79: 503-509, 2008. 金沢医科大学医学会「論文表彰」
2009/07 - 金沢医科大学医学会 金沢医科大学医学会「論文表彰」 A lack of increase in high molecular weight-adiponectin in macroalbuminuric subjects with metabolic syndrome may exert renal and atherosclerotic risks.Diabetes Research and Clinical Practice 79: 503-509, 2008.